FDA approves first vaccine for RSV, a moment six decades in the ... - CNN
May 3, 2023 · After a 60-year scientific quest, the world has its first vaccine to protect against respiratory syncytial virus, or RSV – and more are on the way. On Wednesday, the US Food and Drug Administration...
Map reveals states where RSV cases are surging - Newsweek
Dec 31, 2024 · In the week ending December 21, the following three states had the highest percentage of positive RSV tests – Louisiana (25 percent), Massachusetts (24 percent) and …
Is a virus going around? Details on the flu, COVID, norovirus, RSV
Jan 1, 2025 · The risk of respiratory syncytial virus, or RSV, is on the rise, along with that of other illnesses including the flu, stomach flu and COVID-19.
FDA Approves First Respiratory Syncytial Virus (RSV) Vaccine
Today, the U.S. Food and Drug Administration approved Arexvy, the first respiratory syncytial virus (RSV) vaccine approved for use in the United States. Arexvy is approved for the prevention of...
Respiratory virus activity remains 'high' in US and will ... - ABC News
6 days ago · Respiratory virus activity remains 'high' in US and will 'continue for several more weeks': CDC Cases of flu, COVID and RSV remain high across the U.S., CDC data shows.
A new vaccine is here to protect you and your loved ones from RSV …
Jan 2, 2025 · December and January are peak months for respiratory syncytial virus (RSV) infections. NIH MedlinePlus Magazine has a handy overview of RSV, how it spreads, and how to protect yourself and others from getting sick. Learn what immunizations are available, including vaccines for older adults and antibodies for infants. Don’t let the winter blues get you down—avoid RSV and stay healthy this ...
How to access the new RSV vaccine, and how much will it cost?
Dec 10, 2023 · This year, for the first time, a vaccine is available to help protect older adults against RSV, which is like the common cold for some but can also lead to respiratory infection and...
Progress at last against RSV - Nature
Sep 14, 2023 · Taking a disproportionate toll on young children and older adults, RSV infections can cause severe lower respiratory tract disease and death.
‘A good day’: FDA approves world’s first RSV vaccine - Nature
May 3, 2023 · Those data showed that the shot reduced the risk of people aged 60 and older developing lower respiratory tract disease from RSV by 82.6% and that of developing severe disease by 94.1%.
FDA Approves New Drug to Prevent RSV in Babies and Toddlers
Today, the U.S. Food and Drug Administration approved Beyfortus (nirsevimab-alip) for the prevention of Respiratory Syncytial Virus (RSV) lower respiratory tract disease in neonates …